Published in Gene Therapy Weekly, January 26th, 2006
"Epstein-Barr virus (EBV) is associated with the development of several lymphoid and epithelial malignancies, including Burkitt lymphoma. The EBV latent protein EBNA1 is detectable in almost all types of EBV-associated tumors and is essential for replication and maintenance of the latent episome of EBV."
"We here examined whether the RNAi technique could be employed to suppress expression of EBNA1 in EBV-positive Burkitt lymphoma cells," wrote M. Hong and colleagues,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.